Loading…
The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection
Highlights • HCV core antigen in monitoring antiviral therapy. • Telaprevir therapy in patients infected with HCV genotype1. • Predictive factors of sustained virological response (SVR) in new DAA treatment.
Saved in:
| Published in: | Journal of clinical virology 2015-08, Vol.69, p.68-73 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3 |
| container_end_page | 73 |
| container_issue | |
| container_start_page | 68 |
| container_title | Journal of clinical virology |
| container_volume | 69 |
| creator | Garbuglia, Anna Rosa Lionetti, Raffaella Lapa, Daniele Taibi, Chiara Visco-Comandini, Ubaldo Montalbano, Marzia D'Offizi, Gianpiero Castiglione, Filippo Capobianchi, Maria Rosaria Paci, Paola |
| description | Highlights • HCV core antigen in monitoring antiviral therapy. • Telaprevir therapy in patients infected with HCV genotype1. • Predictive factors of sustained virological response (SVR) in new DAA treatment. |
| doi_str_mv | 10.1016/j.jcv.2015.06.002 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1746886651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386653215001869</els_id><sourcerecordid>1746886651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3</originalsourceid><addsrcrecordid>eNqFUs2O0zAYjBCIXRYegAvykUtS_8SOLSQkVAG70kogKFwtx_nSOqROsJ2ivgcPjEt3OXCAk0f-ZuYwM0XxnOCKYCJWQzXYQ0Ux4RUWFcb0QXFJZMNKrkTzMGMmRSk4oxfFkxgHnImsbh4XF1RQrJikl8XPzQ6QHZ131owouq13fYbeApp6dL3-iuwUABmf3BY86iCBTW7KaAnOb9EGRjMHOLiw-gjb8sYnCD2Eya8-udbkb-dR2kEw8xFlOJvkwKeIfri0-21PUPad0nGGfO_P5k-LR70ZIzy7e6-KL-_ebtbX5e2H9zfrN7elrWuSSkEoqKavCbUW15RCx2lrueGmMZIrawWRTMnWgDBYYm5baQVrFRjCieqAXRUvz75zmL4vEJPeu2hhHI2HaYmaNLWQUghO_k8VSipRM95kKjlTbZhiDNDrObi9CUdNsD71pgede9On3jQWOveWNS_u7Jd2D90fxX1RmfDqTICcx8FB0NHmJC10LuTQdDe5f9q__kt9X_k3OEIcpiX4HLQmOlKN9efTcE67ITxvRgrFfgGGc78g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1698964357</pqid></control><display><type>article</type><title>The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection</title><source>ScienceDirect Journals</source><creator>Garbuglia, Anna Rosa ; Lionetti, Raffaella ; Lapa, Daniele ; Taibi, Chiara ; Visco-Comandini, Ubaldo ; Montalbano, Marzia ; D'Offizi, Gianpiero ; Castiglione, Filippo ; Capobianchi, Maria Rosaria ; Paci, Paola</creator><creatorcontrib>Garbuglia, Anna Rosa ; Lionetti, Raffaella ; Lapa, Daniele ; Taibi, Chiara ; Visco-Comandini, Ubaldo ; Montalbano, Marzia ; D'Offizi, Gianpiero ; Castiglione, Filippo ; Capobianchi, Maria Rosaria ; Paci, Paola</creatorcontrib><description>Highlights • HCV core antigen in monitoring antiviral therapy. • Telaprevir therapy in patients infected with HCV genotype1. • Predictive factors of sustained virological response (SVR) in new DAA treatment.</description><identifier>ISSN: 1386-6532</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2015.06.002</identifier><identifier>PMID: 26209382</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Aged ; Allergy and Immunology ; Antigens, Viral - blood ; Antiviral Agents - therapeutic use ; Drug Therapy, Combination ; EVRearly virological response ; Female ; Genotype ; HCVcore antigen ; Hepacivirus - genetics ; Hepacivirus - immunology ; Hepacivirus - isolation & purification ; Hepatitis C virus ; Hepatitis C, Chronic - diagnosis ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - virology ; Humans ; Infectious Disease ; Interferon-alpha - therapeutic use ; Male ; Middle Aged ; Nuclear polyhedrosis virus ; Oligopeptides - therapeutic use ; Predictive Value of Tests ; Prospective Studies ; Ribavirin - therapeutic use ; RNA, Viral - blood ; ROC Curve ; RVRrapid virological response ; Sensitivity and Specificity ; SVRsustained virological response ; Telaprevir ; Viral Core Proteins - immunology</subject><ispartof>Journal of clinical virology, 2015-08, Vol.69, p.68-73</ispartof><rights>Elsevier B.V.</rights><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3</citedby><cites>FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26209382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garbuglia, Anna Rosa</creatorcontrib><creatorcontrib>Lionetti, Raffaella</creatorcontrib><creatorcontrib>Lapa, Daniele</creatorcontrib><creatorcontrib>Taibi, Chiara</creatorcontrib><creatorcontrib>Visco-Comandini, Ubaldo</creatorcontrib><creatorcontrib>Montalbano, Marzia</creatorcontrib><creatorcontrib>D'Offizi, Gianpiero</creatorcontrib><creatorcontrib>Castiglione, Filippo</creatorcontrib><creatorcontrib>Capobianchi, Maria Rosaria</creatorcontrib><creatorcontrib>Paci, Paola</creatorcontrib><title>The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection</title><title>Journal of clinical virology</title><addtitle>J Clin Virol</addtitle><description>Highlights • HCV core antigen in monitoring antiviral therapy. • Telaprevir therapy in patients infected with HCV genotype1. • Predictive factors of sustained virological response (SVR) in new DAA treatment.</description><subject>Aged</subject><subject>Allergy and Immunology</subject><subject>Antigens, Viral - blood</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>EVRearly virological response</subject><subject>Female</subject><subject>Genotype</subject><subject>HCVcore antigen</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - immunology</subject><subject>Hepacivirus - isolation & purification</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - diagnosis</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - virology</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nuclear polyhedrosis virus</subject><subject>Oligopeptides - therapeutic use</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Ribavirin - therapeutic use</subject><subject>RNA, Viral - blood</subject><subject>ROC Curve</subject><subject>RVRrapid virological response</subject><subject>Sensitivity and Specificity</subject><subject>SVRsustained virological response</subject><subject>Telaprevir</subject><subject>Viral Core Proteins - immunology</subject><issn>1386-6532</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFUs2O0zAYjBCIXRYegAvykUtS_8SOLSQkVAG70kogKFwtx_nSOqROsJ2ivgcPjEt3OXCAk0f-ZuYwM0XxnOCKYCJWQzXYQ0Ux4RUWFcb0QXFJZMNKrkTzMGMmRSk4oxfFkxgHnImsbh4XF1RQrJikl8XPzQ6QHZ131owouq13fYbeApp6dL3-iuwUABmf3BY86iCBTW7KaAnOb9EGRjMHOLiw-gjb8sYnCD2Eya8-udbkb-dR2kEw8xFlOJvkwKeIfri0-21PUPad0nGGfO_P5k-LR70ZIzy7e6-KL-_ebtbX5e2H9zfrN7elrWuSSkEoqKavCbUW15RCx2lrueGmMZIrawWRTMnWgDBYYm5baQVrFRjCieqAXRUvz75zmL4vEJPeu2hhHI2HaYmaNLWQUghO_k8VSipRM95kKjlTbZhiDNDrObi9CUdNsD71pgede9On3jQWOveWNS_u7Jd2D90fxX1RmfDqTICcx8FB0NHmJC10LuTQdDe5f9q__kt9X_k3OEIcpiX4HLQmOlKN9efTcE67ITxvRgrFfgGGc78g</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Garbuglia, Anna Rosa</creator><creator>Lionetti, Raffaella</creator><creator>Lapa, Daniele</creator><creator>Taibi, Chiara</creator><creator>Visco-Comandini, Ubaldo</creator><creator>Montalbano, Marzia</creator><creator>D'Offizi, Gianpiero</creator><creator>Castiglione, Filippo</creator><creator>Capobianchi, Maria Rosaria</creator><creator>Paci, Paola</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20150801</creationdate><title>The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection</title><author>Garbuglia, Anna Rosa ; Lionetti, Raffaella ; Lapa, Daniele ; Taibi, Chiara ; Visco-Comandini, Ubaldo ; Montalbano, Marzia ; D'Offizi, Gianpiero ; Castiglione, Filippo ; Capobianchi, Maria Rosaria ; Paci, Paola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Allergy and Immunology</topic><topic>Antigens, Viral - blood</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>EVRearly virological response</topic><topic>Female</topic><topic>Genotype</topic><topic>HCVcore antigen</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - immunology</topic><topic>Hepacivirus - isolation & purification</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - diagnosis</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - virology</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nuclear polyhedrosis virus</topic><topic>Oligopeptides - therapeutic use</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Ribavirin - therapeutic use</topic><topic>RNA, Viral - blood</topic><topic>ROC Curve</topic><topic>RVRrapid virological response</topic><topic>Sensitivity and Specificity</topic><topic>SVRsustained virological response</topic><topic>Telaprevir</topic><topic>Viral Core Proteins - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garbuglia, Anna Rosa</creatorcontrib><creatorcontrib>Lionetti, Raffaella</creatorcontrib><creatorcontrib>Lapa, Daniele</creatorcontrib><creatorcontrib>Taibi, Chiara</creatorcontrib><creatorcontrib>Visco-Comandini, Ubaldo</creatorcontrib><creatorcontrib>Montalbano, Marzia</creatorcontrib><creatorcontrib>D'Offizi, Gianpiero</creatorcontrib><creatorcontrib>Castiglione, Filippo</creatorcontrib><creatorcontrib>Capobianchi, Maria Rosaria</creatorcontrib><creatorcontrib>Paci, Paola</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garbuglia, Anna Rosa</au><au>Lionetti, Raffaella</au><au>Lapa, Daniele</au><au>Taibi, Chiara</au><au>Visco-Comandini, Ubaldo</au><au>Montalbano, Marzia</au><au>D'Offizi, Gianpiero</au><au>Castiglione, Filippo</au><au>Capobianchi, Maria Rosaria</au><au>Paci, Paola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection</atitle><jtitle>Journal of clinical virology</jtitle><addtitle>J Clin Virol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>69</volume><spage>68</spage><epage>73</epage><pages>68-73</pages><issn>1386-6532</issn><eissn>1873-5967</eissn><abstract>Highlights • HCV core antigen in monitoring antiviral therapy. • Telaprevir therapy in patients infected with HCV genotype1. • Predictive factors of sustained virological response (SVR) in new DAA treatment.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26209382</pmid><doi>10.1016/j.jcv.2015.06.002</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1386-6532 |
| ispartof | Journal of clinical virology, 2015-08, Vol.69, p.68-73 |
| issn | 1386-6532 1873-5967 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1746886651 |
| source | ScienceDirect Journals |
| subjects | Aged Allergy and Immunology Antigens, Viral - blood Antiviral Agents - therapeutic use Drug Therapy, Combination EVRearly virological response Female Genotype HCVcore antigen Hepacivirus - genetics Hepacivirus - immunology Hepacivirus - isolation & purification Hepatitis C virus Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Infectious Disease Interferon-alpha - therapeutic use Male Middle Aged Nuclear polyhedrosis virus Oligopeptides - therapeutic use Predictive Value of Tests Prospective Studies Ribavirin - therapeutic use RNA, Viral - blood ROC Curve RVRrapid virological response Sensitivity and Specificity SVRsustained virological response Telaprevir Viral Core Proteins - immunology |
| title | The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A42%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20significance%20of%20HCV%20core%20antigen%20detection%20during%20Telaprevir/Peg-Interferon/Ribavirin%20therapy%20in%20patients%20with%20HCV%201%20genotype%20infection&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Garbuglia,%20Anna%20Rosa&rft.date=2015-08-01&rft.volume=69&rft.spage=68&rft.epage=73&rft.pages=68-73&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2015.06.002&rft_dat=%3Cproquest_cross%3E1746886651%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-612e97f412cc0422ed52bc5a5a7a859cc618398bae6a0805cb8c63b9ea1519de3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1698964357&rft_id=info:pmid/26209382&rfr_iscdi=true |